Cargando…
Should serum biomarker monitoring replace primary antifungal chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer therapy? A PRO/CON debate
Fungal infection exacts a severe burden on patients with acute leukaemia. Azole prophylaxis attempts to mitigate this impact but is associated with toxicity and cost as well as the potential to select for resistance. The development of biomarkers including galactomannan and β-1,3-d-glucan may improv...
Autores principales: | Harrison, Thomas, Partridge, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9305506/ https://www.ncbi.nlm.nih.gov/pubmed/35873179 http://dx.doi.org/10.1093/jacamr/dlac075 |
Ejemplares similares
-
CON: Serum biomarker monitoring should not replace primary antifungal
chemoprophylaxis in patients with acute leukaemia receiving systemic anti-cancer
therapy
por: Howard, Alex, et al.
Publicado: (2022) -
Should ceftriaxone-resistant Enterobacterales be tested for ESBLs? A PRO/CON debate
por: Villegas, Maria Virginia, et al.
Publicado: (2021) -
Does procalcitonin have clinical utility in the management of paediatric community-acquired pneumonia? A PRO/CON debate
por: Chiotos, Kathleen, et al.
Publicado: (2021) -
Pro/con clinical debate: Hydroxyethylstarches should be avoided in septic patients
por: Schortgen, Frédérique, et al.
Publicado: (2003) -
Venous Thromboembolism Risk Stratification and Chemoprophylaxis: A Meta-Analysis Finds No Benefit, More Risk
por: Swanson, Eric
Publicado: (2017)